Home > PE Ratio > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of KWALITY PHARMACEUTICALS is 44.20.

Share Price ₹3,444.8Aug 14,2026
Market Cap ₹3,582.5 Cr
Earnings-TTM₹81.0 CrTTM-Consolidated Results
Price/Earnings44.20xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of KWALITY PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of KWALITY PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹3,582.5 Cr] as on Aug 14,2026

(/) Earnings [ ₹81.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 44.20x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay 44.20 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KWALITY PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of KWALITY PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of KWALITY PHARMACEUTICALS


PE Ratio Performance Analysis for KWALITY PHARMACEUTICALS

- KWALITY PHARMACEUTICALS 's latest p/e ratio is 44.20x.

- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 16.42x.

- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 17.85x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 22.63x.

- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 5.02x.


How does KWALITY PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
KWALITY PHARMACEUTICALS 81.0444.203,582.5
SUN PHARMACEUTICAL INDUSTRIES LTD12,172.7037.94461,848.0
DIVIS LABORATORIES LTD2,925.0077.14225,648.0
TORRENT PHARMACEUTICALS LTD2,156.0085.39184,109.0
CIPLA LTD3,364.8434.81117,139.0
DR REDDYS LABORATORIES LTD3,169.3031.66100,328.0
MANKIND PHARMA LTD2,055.1148.6399,945.0
LUPIN LTD5,551.0118.41102,192.0
ZYDUS LIFESCIENCES LTD4,492.2025.31113,715.0
AUROBINDO PHARMA LTD3,712.7425.6995,397.6
LAURUS LABS LTD1,090.7689.9098,064.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KWALITY PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.41x
Max industry PE 89.90x
Median industry PE 37.94x
Average industry PE 47.19x



You may also like the below Video Courses